Effect of incretin therapies compared to pioglitazone and gliclazide in non-alcoholic fatty liver disease in diabetic patients not controlled on metformin alone: An observational, pilot study. [electronic resource]
Producer: 20171120Description: 194-201 p. digitalISSN:- 1579-2021
- Aged
- Aged, 80 and over
- Diabetes Mellitus, Type 2 -- complications
- Drug Therapy, Combination
- Exenatide
- Female
- Gliclazide -- administration & dosage
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemic Agents -- administration & dosage
- Incretins -- administration & dosage
- Lipids -- blood
- Liraglutide -- administration & dosage
- Liver Function Tests
- Male
- Metabolic Syndrome -- complications
- Metformin -- administration & dosage
- Middle Aged
- Non-alcoholic Fatty Liver Disease -- diagnostic imaging
- Peptides -- administration & dosage
- Pilot Projects
- Pioglitazone
- Prospective Studies
- Sitagliptin Phosphate -- administration & dosage
- Thiazolidinediones -- administration & dosage
- Venoms -- administration & dosage
- Waist Circumference -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.